NEPTF — Neptune Wellness Solutions Balance Sheet
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- $0.00m
- $3.76m
- $52.62m
Annual balance sheet for Neptune Wellness Solutions, fiscal year end - March 31st, USD millions except per share, conversion factor applied.
2019 March 31st | 2020 March 31st | R2021 March 31st | 2022 March 31st | 2023 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | USG | USG | USG |
| Status: | fx Final | fx Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 9.52 | 11.8 | 59.9 | 8.75 | 2.01 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 4.35 | 7.67 | 7.39 | 7.55 | 7.51 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 18.5 | 27.6 | 89.5 | 37.4 | 23.6 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 35.2 | 43.7 | 40.2 | 23.7 | 3.34 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Total Assets | 67.6 | 120 | 187 | 105 | 30.9 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 15 | 12.2 | 34.8 | 30.3 | 41 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 15.9 | 17.9 | 71.6 | 56.8 | 42.9 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 51.7 | 102 | 115 | 48.1 | -11.9 |
| Total Liabilities & Shareholders' Equity | 67.6 | 120 | 187 | 105 | 30.9 |
| Total Common Shares Outstanding |